---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-070415"
form_type: "8-K"
ticker: "RVRC"
cik: "0001839140"
company_name: "Revium Rx."
filed_at: "2026-06-22T13:42:07+00:00"
generated_at: "2026-06-22T13:43:14.923987+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Revium Rx COO, President and Director Inna Martin resigns due to differences in expectations

## Summary
- Inna Martin resigned as Director, COO, and President effective June 16, 2026, due to differences in expectations with the company.
- Separation agreement: employment and consultancy with Revium Ltd. ends Sep 10, 2026; vested stock option exercise period extended to Sep 30, 2028 for up to 2,440,000 shares.
- Shares and options subject to sale restrictions per Separation Agreement.

## SEC filing metadata
- accession: 0001213900-26-070415
- form_type: 8-K
- ticker: RVRC
- cik: 0001839140
- company_name: Revium Rx.
- filed_at: 2026-06-22T13:42:07+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839140/000121390026070415/0001213900-26-070415-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839140/000121390026070415/ea0295431-8k_revium.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-070415
- JSON: https://secwatch.observer/filing/0001213900-26-070415.json
- Plain text: https://secwatch.observer/filing/0001213900-26-070415.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.